title: Effects of caffeine on Ca2+ fluxes and secretion in bovine chromaffin cells.
abstract: The effects of caffeine on Ca2+ fluxes and catecholamine secretion in bovine adrenal chromaffin cells were examined. Caffeine inhibited secretion. 45Ca2+ uptake and cytosolic Ca2+ concentration ([Ca2+]i) rise induced by the nicotinic receptor agonist 1.1-dimethyl- 4-phenylpiperazinium (DMPP) and the Na+ channel activator veratridine. The inhibitory effect of caffeine on high K(+)-induced secretion was smaller than that on DMPP- and veratridine-induced responses. Caffeine only slightly inhibited high K(+)-induced 45Ca2+ uptake and did not affect [Ca2+]i rise. Caffeine also inhibited muscarinic receptor-mediated inositol phosphate generation. Our results suggest that the inhibitory effects of caffeine on bovine chromaffin cells mainly occur at both muscarinic and nicotinic receptors as well as at the voltage-dependent Na+ channels and to a smaller extent at site(s) distal to Ca2+ entry. The effects of caffeine on nicotinic receptors but not on muscarinic receptors can be explained by its ability to raise intracellular cAMP.
authors.affiliation: Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC.
authors.forename: P S
authors.initials: PS
authors.lastname: Liu
authors.forename: Y J
authors.initials: YJ
authors.lastname: Lin
authors.forename: L S
authors.initials: LS
authors.lastname: Kao
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000313:Adrenal Medulla / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism*; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors; D002217:Carbachol / Q000037:antagonists & inhibitors; D002395:Catecholamines / Q000378:metabolism*; D002417:Cattle; D005576:Colforsin / Q000494:pharmacology; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D007295:Inositol Phosphates / Q000378:metabolism; D018722:Nicotinic Agonists / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D013729:Terpenes / Q000494:pharmacology; D019284:Thapsigargin; D014701:Veratridine / Q000494:pharmacology
chemical_list: D002395:Catecholamines; D007295:Inositol Phosphates; D018722:Nicotinic Agonists; D010726:Phosphodiesterase Inhibitors; D013729:Terpenes; D005576:Colforsin; D002110:Caffeine; D004246:Dimethylphenylpiperazinium Iodide; D003994:Bucladesine; D019284:Thapsigargin; D014701:Veratridine; D002217:Carbachol; D000252:Calcium-Transporting ATPases; D002118:Calcium; D015056:1-Methyl-3-isobutylxanthine